Comparing the Oncological Risk of Hormonal and Non-Hormonal Contraceptives in Cervical Cancer: A Literature Review
DOI:
https://doi.org/10.59141/-.v8i1.523Keywords:
cervical cancer, hormonal contraceptives, IUD, reproductive health riskAbstract
Cervical cancer is a malignancy with high morbidity and mortality rates among women worldwide, including Indonesia. While high-risk HPV (hr-HPV) infection is the primary cause, contraceptive use is strongly suspected to act as a significant cofactor in cervical carcinogenesis. This research aims to analyze the comparison of cervical cancer risk between hormonal and non-hormonal contraceptive use through a comprehensive literature review. The study design was a literature review with a systematic search strategy on PubMed and Google Scholar databases. Ten original research articles (5 national and 5 international journals) published between 2016 and 2026 were selected based on inclusion and exclusion criteria. The analysis results showed that 60% of the studies reported a significant association between long-term hormonal contraceptive use ≥ 5 years and an increased risk of cervical cancer, with Odds Ratio (OR) values ranging from 2.4 to 7.0. In contrast, non-hormonal contraceptive use, specifically the Intrauterine Device (IUD), consistently showed a lower risk profile or provided a protective effect against pre-cancerous lesions. However, some studies showed variations influenced by confounding factors such as age at first marriage and parity. Long-term hormonal contraceptive use is associated with an increased risk of cervical cancer, while non-hormonal contraceptives (IUD) have a better oncological safety profile. Comprehensive counseling and routine screening (VIA/Pap Smear) are required for contraceptive acceptors, especially long-term hormonal method users.
Downloads
References
Adhikari, I., Eriksson, T., Luostarinen, T., Apter, D., Lehtinen, M., & Paavonen, J. (2019). Is the risk of cervical atypia associated with the interval between menarche and the start of sexual activity? A population-based cohort study. BMJ Open, 9(11), 1–7. https://doi.org/10.1136/bmjopen-2019-030091
Amelia, N. R., Ngo, N. F., & Toruan, V. M. L. (2022). Hubungan usia pertama menikah, paritas dan lama penggunaan kontrasepsi hormonal dengan kejadian kanker serviks di RSUD Abdul Wahab Sjahranie Samarinda. Jurnal Verdure, 4, 378–384.
Anastasiou, E., McCarthy, K. J., Gollub, E. L., Ralph, L., van de Wijgert, J. H. H. M., & Jones, H. E. (2022). The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review. Contraception, 107, 1–9. https://doi.org/10.1016/j.contraception.2021.10.018
Bahamondes, L., Bahamondes, M. V., & Shulman, L. P. (2015). Non-contraceptive benefits of hormonal and intrauterine reversible contraceptive methods. Human Reproduction Update, 21(5), 640–651.
Bovo, A. C., Pedrão, P. G., Guimarães, Y. M., Godoy, L. R., Resende, J. C. P., Longatto-Filho, A., & Reis, R. dos. (2023). Combined oral contraceptive use and the risk of cervical cancer: Literature review. Revista Brasileira de Ginecologia e Obstetricia, 45, E818–E824. https://doi.org/10.1055/s-0043-1776403
Corrêa, C. M., Zeferino, L. C., Juliato, C. T., & Bahamondes, L. (2025). Association of cervical cancer and intrauterine device use: A narrative review. BMC Women’s Health. https://doi.org/10.1186/s12905-025-04239-4
Guida, F., Kidman, R., Ferlay, J., Schüz, J., Soerjomataram, I., Kithaka, B., Ginsburg, O., Mailhot Vega, R. B., Galukande, M., Parham, G., Vaccarella, S., Canfell, K., Ilbawi, A. M., Anderson, B. O., Bray, F., dos-Santos-Silva, I., & McCormack, V. (2022). Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nature Medicine, 28, 2563–2572. https://doi.org/10.1038/s41591-022-02109-2
Gul, S., Ali, T., Bibi, R., Hanif, S., Gul, S., & Farooqi, K. (2022). Association between hormonal contraceptives and cervical neoplasia in local population of Khyber Pakhtunkhwa. Pakistan Journal of Medical and Health Sciences, 16, 489–491. https://doi.org/10.53350/pjmhs22169489
Hidayati, N. (2020). Hubungan kejadian kanker serviks dengan riwayat penggunaan alat kontrasepsi hormonal di RSUD Dr. H. Abdul Moeloek Bandar Lampung tahun 2018. Akbid Wira Buana, 8, 1–9.
Jahanfar, S., Mortazavi, J., Lapidow, A., Cu, C., Al Abosy, J., Morris, K., Becerra-Mateus, J. C., Steinfeldt, M., Maurer, O., Bohang, J., Badawy, M., & Ali, M. (2024). Assessing the impact of contraceptive use on reproductive cancer risk among women of reproductive age—A systematic review. Frontiers in Global Women’s Health, 5, 1–16. https://doi.org/10.3389/fgwh.2024.1487820
Kamani, M. O., Akgor, U., & Gültekin, M. (2022). Review of the literature on combined oral contraceptives and cancer. Ecancermedicalscience, 16. https://doi.org/10.3332/ecancer.2022.1416
Kiweewa, F. M., Brown, E., Mishra, A., Nair, G., Palanee-Phillips, T., Mgodi, N., Nakabiito, C., Chakhtoura, N., Hillier, S. L., Baeten, J. M., Soto-Torres, L., Schwartz, K., Makanani, B., Martinson, F., Bekker, L. G., Govender, V., & Mhlanga, F. (2019). Acquisition of sexually transmitted infections among women using a variety of contraceptive options: A prospective study among high-risk African women. Journal of the International AIDS Society, 22, 1–7. https://doi.org/10.1002/jia2.25257
Loopik, D. L., IntHout, J., Melchers, W. J. G., Massuger, L. F. A. G., Bekkers, R. L. M., & Siebers, A. G. (2020). Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: A population-based study. European Journal of Cancer, 124, 102–109. https://doi.org/10.1016/j.ejca.2019.10.009
Mengistie, B. A., Aragaw, G. M., Anteneh, T. A., Wondie, K. Y., Kassie, A. T., Abuhay, A. E., Biset, W. M., Mulatu, G. G., & Tsega, N. T. (2025). Prevalence and determinants of precancerous cervical lesions among women screened for cervical cancer in Africa: A systematic review and meta-analysis. PLoS ONE, 20, 1–24. https://doi.org/10.1371/journal.pone.0338484
Muchtariza, S., & Masnarivan, Y. (2020). Systematic review: Ketahanan hidup penderita kanker serviks di Indonesia. Jurnal Kesehatan Medika Saintika, 11, 253–257.
Mukti, G. A. (2021). Determinan pemanfaatan skrining kanker serviks oleh wanita di Asia: A systematic review. Jurnal Ilmiah Kebidanan Indonesia, 11, 135–141. https://doi.org/10.33221/jiki.v11i03.1223
Mulyandari, M., Mustikarani, I. K., & Afni, A. C. N. (2020). Hubungan lama penggunaan alat kontrasepsi oral (pil KB) dan intrauterine device (IUD) terhadap resiko kanker serviks di Puskesmas Ngoresan Surakarta. Jurnal Keperawatan Malang, 5, 72–79. https://doi.org/10.36916/jkm.v5i2.113
Nazrul, N., Rahman, A., de Fouw, M., Campbell, C., Koot, J., Kulsum, M. U., Ahmed, M. S., Haider, S. S., Hossain, M. A., Islam, K. M., Nessa, A., Amrin, M., Stekelenburg, J., & Beltman, J. J. (2025). Cervical high-risk human papillomavirus infection and its associated risk factors: A community-based cross-sectional study in hard-to-reach areas in Bangladesh. BMJ Open, 15, 1–12. https://doi.org/10.1136/bmjopen-2025-103915
Rusfandi, A. A., & Indrawan, I. W. A. (2025). Alat kontrasepsi hormonal vs non-hormonal untuk wanita berkaitan dengan kanker serviks. Jurnal Kedokteran Brawijaya, 33, 218–225.
Rusfandi, A. A., & Indrawan, I. W. A. (2025). Hormonal vs. non-hormonal contraceptives for women in relation to cervical cancer: A systematic review. Jurnal Kedokteran Brawijaya, 218–225.
Shintya, L. A. (2023). Penggunaan kontrasepsi hormonal dengan kejadian kanker serviks. Klabat Journal of Nursing, 5, 90. https://doi.org/10.37771/kjn.v5i2.1018
Sholichah, N., Sulastri, I., & Fergiana, T. G. (2024). Hubungan penggunaan kontrasepsi IUD dengan kejadian kanker serviks di Puskesmas Purworejo. Jurnal Komunikasi Kesehatan, 15, 14–19.
Stelzle, D., Tanaka, L. F., Lee, K. K., Ibrahim Khalil, A., Baussano, I., Shah, A. S. V., McAllister, D. A., Gottlieb, S. L., Klug, S. J., Winkler, A. S., Bray, F., Baggaley, R., Clifford, G. M., Broutet, N., & Dalal, S. (2021). Estimates of the global burden of cervical cancer associated with HIV. The Lancet Global Health, 9, e161–e169. https://doi.org/10.1016/S2214-109X(20)30459-9
Yimer, N. B., Mohammed, M. A., Solomon, K., Tadese, M., Grutzmacher, S., Meikena, H. K., Alemnew, B., Sharew, N. T., & Habtewold, T. D. (2021). Cervical cancer screening uptake in Sub-Saharan Africa: A systematic review and meta-analysis. Public Health, 195, 105–111. https://doi.org/10.1016/j.puhe.2021.04.014
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Haifa Hasna Putri, Fiona Paramitha
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
